Teladoc Health, Inc.
TDOC- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001477449
In the last 90 days, Teladoc Health, Inc. insiders filed 0 open-market purchases and 10 sales; 347 institutions reported holding it in 13F filings for Q2 2026, worth $1.29B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Teladoc Health, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 10 filings
- 6 insiders, $509.4K in total
- Insiders trading
- 6
- Net value
- −$509.4K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Teladoc Health, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Divita Charles III | CHIEF EXECUTIVE OFFICER | 465,535 | Sep 14, 2026 | 7 |
| Nueno Carlos | President, International | 64,744 | Sep 3, 2026 | 4 |
| Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | 117,616 | Sep 3, 2026 | 4 |
| Bliss Kelly | President, U.S. Group Health | 92,832 | Sep 3, 2026 | 7 |
| Catapano Joseph Ronald | Chief Accounting Officer | 12,865 | Sep 3, 2026 | 7 |
| Rodrigues Fernando M. | President of BetterHelp | 0 | Sep 3, 2026 | 5 |
| Grasher Michael F | Chief Financial Officer | – | Sep 1, 2026 | 1 |
| Anquillare Mark V | Director | – | Aug 4, 2026 | 1 |
| Shedlarz David L | Director | 61,266 | May 21, 2026 | 1 |
| Snow David B Jr | Director | 113,032 | May 21, 2026 | 1 |
| Fenwick Sandra L | Director | 12,070 | May 21, 2026 | 1 |
| Paulus Kenneth H | Director | 10,000 | May 21, 2026 | 2 |
| Smith Mark Douglas | Director | 8,355 | May 21, 2026 | 1 |
| Jacobson Catherine | Director | 66,853 | May 21, 2026 | 1 |
| Salka Susan R | Director | – | Apr 1, 2026 | 1 |
| Smith Michael S | Director | – | Feb 19, 2026 | 1 |
| Evans Jason Eric | Director | 9,145 | Dec 22, 2025 | 1 |
| Murthy Mala | CHIEF FINANCIAL OFFICER | 142,385 | Sep 3, 2025 | 0 |
| McKinley Thomas | Director | 56,544 | May 23, 2025 | 0 |
| Turitz Andrew | EVP, CORPORATE DEVELOPMENT | 20,773 | Sep 5, 2024 | 0 |
| Raman-Tangella Vidya | CHIEF MEDICAL OFFICER | 33,665 | Sep 5, 2024 | 0 |
| Verstraete Stephany | CHIEF MARKETING OFFICER | 48,843 | Sep 4, 2024 | 0 |
| Trencher Daniel | CHIEF STRATEGY OFFICER | 31,465 | Sep 4, 2024 | 0 |
| Geshuri Arnnon | CHIEF PEOPLE OFFICER | 44,914 | Sep 4, 2024 | 0 |
| Waters Michael Willem | CHIEF OPERATING OFFICER | 78,309 | Sep 4, 2024 | 0 |
| Nanis Nikolaos P. | Chief Technology Officer | 75,410 | Sep 4, 2024 | 0 |
| Cave James L. | INTERIM CAO | 13,808 | Sep 4, 2024 | 0 |
| Kornwasser Laizer | Advisor to the CEO | 99,929 | Aug 5, 2024 | 0 |
| Daniel Karen L | Director | 36,995 | May 24, 2024 | 0 |
| Gorevic Jason N | CHIEF EXECUTIVE OFFICER | 653,073 | Mar 20, 2024 | 0 |
| Napolitano Richard J | CHIEF ACCOUNTING OFFICER | 18,077 | Mar 20, 2024 | 0 |
| Jensen Claus Torp | CHIEF INNOVATION OFFICER | 20,703 | Dec 5, 2023 | 0 |
| Frist William H. | Director | 12,918 | May 31, 2022 | 0 |
| Bischoff Christopher | Director | 7,195 | May 18, 2022 | 0 |
| Sides David William | Chief Operating Officer | 11,031 | Aug 2, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2024 (view filing) | Apr 2 | 1 day | Nanis Nikolaos P.Chief Technology Officer | SSale | −461 | $14.31 | −$6.60K | −0.6%70.6K after | |
| Apr 17, 2024 (view filing) | Apr 17 | Same day | Trencher DanielCHIEF STRATEGY OFFICER | SSale | −1.00K | $13.21 | −$13.2K | −3.7%26.2K after | |
| May 2, 2024 (view filing) | May 2 | Same day | Raman-Tangella VidyaCHIEF MEDICAL OFFICER | SSale | −3.69K | $12.69 | −$46.8K | −11.2%29.2K after | |
| May 2, 2024 (view filing) | May 2 | Same day | Waters Michael WillemCHIEF OPERATING OFFICER | SSale | −5.79K | $12.69 | −$73.5K | −8.2%64.9K after | |
| May 2, 2024 (view filing) | May 2 | Same day | Kornwasser LaizerPRESIDENT, ENTERPRISE GROWTH | SSale | −10.4K | $12.69 | −$132.1K | −10.8%86.1K after | |
| May 17, 2024 (view filing) | May 17 | Same day | Trencher DanielCHIEF STRATEGY OFFICER | SSale | −1.00K | $12.83 | −$12.8K | −3.8%25.2K after | |
| May 24, 2024 (view filing) | May 23 | 1 day | Daniel Karen LDirector | SSale | −9.83K | $11.90 | −$117.0K | −21.0%37.0K after | 10b5-1 |
| Jun 4, 2024 (view filing) | Jun 3 | 1 day | Vandervoort Adam CCHIEF LEGAL OFFICER, SECRETARY | SSale | −4.01K | $11.16 | −$44.8K | −8.9%41.3K after | |
| Jun 4, 2024 (view filing) | Jun 3 | 1 day | Nanis Nikolaos P.Chief Technology Officer | SSale | −1.04K | $11.16 | −$11.6K | −1.4%72.4K after | |
| Jun 4, 2024 (view filing) | Jun 3 | 1 day | Cave James L.INTERIM CAO | SSale | −854 | $11.16 | −$9.53K | −6.4%12.5K after | |
| Jun 4, 2024 (view filing) | Jun 3 | 1 day | Verstraete StephanyCHIEF MARKETING OFFICER | SSale | −2.10K | $11.16 | −$23.4K | −3.4%60.2K after | |
| Jun 4, 2024 (view filing) | Jun 3 | 1 day | Trencher DanielCHIEF STRATEGY OFFICER | SSale | −1.79K | $11.16 | −$20.0K | −5.9%28.3K after | |
| Jun 4, 2024 (view filing) | May 31-Jun 4 | 4 days | Raman-Tangella VidyaCHIEF MEDICAL OFFICER | SSale | −5.00K | $11.18 | −$55.9K | −15.5%27.3K after | 3 lots10b5-1 |
| Jun 4, 2024 (view filing) | Jun 3 | 1 day | Kornwasser LaizerPRESIDENT, ENTERPRISE GROWTH | SSale | −4.81K | $11.16 | −$53.7K | −5.0%90.6K after | |
| Jun 4, 2024 (view filing) | Jun 3 | 1 day | Waters Michael WillemCHIEF OPERATING OFFICER | SSale | −4.25K | $11.16 | −$47.4K | −5.8%68.9K after | |
| Jun 4, 2024 (view filing) | Jun 3 | 1 day | Turitz AndrewEVP, CORPORATE DEVELOPMENT | SSale | −1.63K | $11.16 | −$18.2K | −4.1%37.7K after | |
| Jun 4, 2024 (view filing) | Jun 3 | 1 day | Geshuri ArnnonCHIEF PEOPLE OFFICER | SSale | −1.81K | $11.16 | −$20.2K | −4.2%41.7K after | |
| Jun 4, 2024 (view filing) | Jun 3 | 1 day | Murthy MalaACTING CEO, CFO | SSale | −8.81K | $11.16 | −$98.3K | −10.1%78.7K after | |
| Jul 2, 2024 (view filing) | Jul 2 | Same day | Nanis Nikolaos P.Chief Technology Officer | SSale | −442 | $9.39 | −$4.15K | −0.6%73.2K after | |
| Aug 5, 2024 (view filing) | Aug 2 | 3 days | Kornwasser LaizerAdvisor to the CEO | SSale | −10.9K | $8.14 | −$88.6K | −9.8%99.9K after | |
| Aug 5, 2024 (view filing) | Aug 2 | 3 days | Raman-Tangella VidyaCHIEF MEDICAL OFFICER | SSale | −3.86K | $8.14 | −$31.4K | −10.3%33.7K after | |
| Aug 5, 2024 (view filing) | Aug 2 | 3 days | Waters Michael WillemCHIEF OPERATING OFFICER | SSale | −6.05K | $8.14 | −$49.3K | −7.5%74.2K after | |
| Aug 6, 2024 (view filing) | Aug 5 | 1 day | Raman-Tangella VidyaCHIEF MEDICAL OFFICER | SSale | −1.54K | $7.33 | −$11.3K | −4.6%32.1K after | 10b5-1 |
| Aug 8, 2024 (view filing) | Aug 6-7 | 2 days | McKinley ThomasDirector | PPurchase | +11.0K | $7.43 | +$81.8K | +45.7%35.1K after | 2 lots |
| Aug 8, 2024 (view filing) | Aug 7 | 1 day | Verstraete StephanyCHIEF MARKETING OFFICER | SSale | −15.0K | $7.60 | −$114.0K | −24.9%45.2K after | 10b5-1 |
| Aug 13, 2024 (view filing) | Aug 12 | 1 day | Nanis Nikolaos P.Chief Technology Officer | SSale | −206 | $7.14 | −$1.47K | −0.3%73.6K after | |
| Aug 19, 2024 (view filing) | Aug 15 | 4 days | Smith Mark DouglasDirector | PPurchase | +4.00K | $7.08 | +$28.3K | +91.8%8.36K after | |
| Sep 4, 2024 (view filing) | Sep 3 | 1 day | Raman-Tangella VidyaCHIEF MEDICAL OFFICER | SSale | −1.11K | $7.16 | −$7.98K | −3.2%34.1K after | |
| Sep 4, 2024 (view filing) | Sep 3 | 1 day | Turitz AndrewEVP, CORPORATE DEVELOPMENT | SSale | −1.62K | $7.16 | −$11.6K | −3.7%41.5K after | |
| Sep 4, 2024 (view filing) | Sep 3 | 1 day | Waters Michael WillemCHIEF OPERATING OFFICER | SSale | −4.22K | $7.16 | −$30.2K | −5.1%78.3K after | |
| Sep 4, 2024 (view filing) | Sep 3 | 1 day | Trencher DanielCHIEF STRATEGY OFFICER | SSale | −1.78K | $7.16 | −$12.7K | −5.3%31.5K after | |
| Sep 4, 2024 (view filing) | Sep 3 | 1 day | Cave James L.INTERIM CAO | SSale | −555 | $7.16 | −$3.97K | −3.9%13.8K after | |
| Sep 4, 2024 (view filing) | Sep 3 | 1 day | Verstraete StephanyCHIEF MARKETING OFFICER | SSale | −2.08K | $7.16 | −$14.9K | −4.1%48.8K after | |
| Sep 4, 2024 (view filing) | Sep 3 | 1 day | Vandervoort Adam CCHIEF LEGAL OFFICER, SECRETARY | SSale | −2.82K | $7.16 | −$20.2K | −5.7%46.3K after | |
| Sep 4, 2024 (view filing) | Sep 3 | 1 day | Nanis Nikolaos P.Chief Technology Officer | SSale | −1.03K | $7.16 | −$7.40K | −1.4%75.4K after | |
| Sep 4, 2024 (view filing) | Sep 3 | 1 day | Murthy MalaCHIEF FINANCIAL OFFICER | SSale | −8.75K | $7.16 | −$62.6K | −9.3%85.8K after | |
| Sep 4, 2024 (view filing) | Sep 3 | 1 day | Geshuri ArnnonCHIEF PEOPLE OFFICER | SSale | −1.79K | $7.16 | −$12.9K | −3.8%44.9K after | |
| Sep 5, 2024 (view filing) | Sep 4 | 1 day | Raman-Tangella VidyaCHIEF MEDICAL OFFICER | SSale | −468 | $7.26 | −$3.40K | −1.4%33.7K after | 10b5-1 |
| Sep 5, 2024 (view filing) | Sep 4 | 1 day | Turitz AndrewEVP, CORPORATE DEVELOPMENT | SSale | −20.8K | $7.26 | −$150.8K | −50.0%20.8K after | 10b5-1 |
| Sep 13, 2024 (view filing) | Sep 12 | 1 day | McKinley ThomasDirector | PPurchase | +4.00K | $7.69 | +$30.8K | +11.4%39.1K after | |
| Oct 2, 2024 (view filing) | Oct 2 | Same day | Bliss KellyPresident, U.S. Group Health | SSale | −897 | $8.68 | −$7.79K | −3.1%28.2K after | |
| Dec 3, 2024 (view filing) | Dec 2 | 1 day | Bliss KellyPresident, U.S. Group Health | SSale | −2.04K | $11.93 | −$24.3K | −6.0%32.2K after | |
| Dec 3, 2024 (view filing) | Dec 2-3 | 1 day | Rodrigues Fernando M.President of BetterHelp | SSale | −22.0K | $11.38 | −$249.9K | −100.0%0 after | 2 lots |
| Dec 3, 2024 (view filing) | Dec 2 | 1 day | Murthy MalaCHIEF FINANCIAL OFFICER | SSale | −8.78K | $11.93 | −$104.8K | −8.6%92.8K after | |
| Dec 3, 2024 (view filing) | Dec 2 | 1 day | Vandervoort Adam CCHIEF LEGAL OFFICER, SECRETARY | SSale | −4.00K | $11.93 | −$47.8K | −7.4%50.0K after | |
| Dec 3, 2024 (view filing) | Dec 2-3 | 1 day | Nueno CarlosPresident, International | SSale | −5.28K | $11.55 | −$61.0K | −100.0%0 after | 2 lots10b5-1 |
| Mar 4, 2025 (view filing) | Mar 3 | 1 day | Vandervoort Adam CCHIEF LEGAL OFFICER, SECRETARY | SSale | −3.94K | $9.68 | −$38.1K | −6.8%53.9K after | |
| Mar 4, 2025 (view filing) | Mar 3 | 1 day | Bliss KellyPresident, U.S. Group Health | SSale | −2.90K | $9.68 | −$28.1K | −7.6%35.4K after | |
| Mar 4, 2025 (view filing) | Mar 3 | 1 day | Nueno CarlosPresident, International | SSale | −2.35K | $9.68 | −$22.7K | −44.5%2.93K after | |
| Mar 4, 2025 (view filing) | Mar 3 | 1 day | Murthy MalaCHIEF FINANCIAL OFFICER | SSale | −8.63K | $9.68 | −$83.5K | −7.9%100.0K after |